Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
European Journal of Obstetrics, Gynecology, and Reproductive Biology|December 26, 2025
Does BMI affect treatment outcomes following intradetrusor onabotulinumtoxinA (Botox) injection in patients with Overactive Bladder (OAB)?Miriam O'Kane, Adith Thomas, Erin Fitzsimons-West, et al.Current Medical Research and Opinion|September 25, 2013
Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysisNiklas Bergvall, Charles Makin, Raquel Lahoz, et al.International Journal of Cardiology|March 19, 2014
Bariatric surgery and its impact on cardiovascular disease and mortality: a systematic review and meta-analysisChun Shing Kwok, Ashish Pradhan, Muhammad A Khan, et al.ERJ Open Research|October 29, 2025
COMPAIR: a comparison of directly supervised clinic <i>versus</i> virtually supervised home spirometryAshish Pradhan, Jacqui Pollington, Dinesh Saralaya, et al.Annals of Clinical and Translational Neurology|February 23, 2021
Safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trialRobert A Bermel, Emmanuelle Waubant, Gabriel Pardo, et al.Journal of Medical Economics|July 15, 2014
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysisNiklas Bergvall, Allison A Petrilla, Swapna U Karkare, et al.Plos One|February 12, 2014
Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database studyNiklas Bergvall, Charles Makin, Raquel Lahoz, et al.Neurology|September 3, 2021
Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple SclerosisStephen L Hauser, Ludwig Kappos, Xavier Montalban, et al.Multiple Sclerosis and Related Disorders|October 12, 2020
Safety results of administering ocrelizumab per a shorter infusion protocol in patients with primary progressive and relapsing multiple sclerosisTimothy L Vollmer, Jeffrey A Cohen, Enrique Alvarez, et al.The American Journal of Cardiology|June 26, 2016
Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary InterventionChun Shing Kwok, Denise Tiong, Ashish Pradhan, et al.Pageof 4